Table I.
Patient characteristics.
| Characteristic | n (%) |
|---|---|
| Male/female ratio | 116/69 |
| Median age, years (range) | 49 (16–82) |
| ≤40 | 54 (29.2) |
| 40–60 | 87 (47.0) |
| 60–75 | 38 (20.6) |
| >75 | 6 (3.2) |
| Ann Arbor stage | |
| I | 23 (12.4) |
| II | 38 (20.6) |
| III | 27 (14.6) |
| IV | 97(52.4) |
| LDH, normalized | |
| ≤1 | 108 (58.4) |
| 1–3 | 57 (30.8) |
| >3 | 20 (10.8) |
| ECOG performance status | |
| 0–1 | 142 (76.8) |
| ≥2 | 43 (23.2) |
| Extranodal disease | |
| Bone marrow | 18 (9.7) |
| CNS | 11 (5.9) |
| Liver | 17 (9.2) |
| GI tract | 41 (22.2) |
| Lung | 14 (7.6) |
| Others | 103 (55.7) |
| Standard IPI score | |
| 0–1 | 74 (40.0) |
| 2 | 40 (21.6) |
| 3 | 40 (21.6) |
| 4–5 | 31 (16.8) |
| Revised IPI score | |
| 0 | 35 (18.9) |
| 1–2 | 79 (42.7) |
| 3–5 | 71 (38.4) |
| NCCN-IPI score | |
| 0–1 | 38 (20.6) |
| 2–3 | 90 (48.6) |
| 4–5 | 45 (24.3) |
| 6–8 | 12 (6.5) |
All values are presented as n (%). ECOG, Eastern Cooperative Oncology Group; CNS, central nervous system; NCCN-IPI, enhanced International Prognostic Index; LDH, lactate dehydrogenase.